2019 SABCS Public Wednesday

Masakazu Toi, MD, PhD, discusses Addition of S-1 to Post-operative Endocrine Therapy Improves Outcomes for Patients with Hormone Receptor-positive, HER2-negative Breast Cancer during Opening Press Conference

San Antonio, TX - SABCS 2019 San Antonio Breast Cancer Symposium - Masakazu Toi, MD, PhD, discusses Addition of S-1 to Post-operative Endocrine Therapy Improves Outcomes for Patients with Hormone Receptor-positive, HER2-negative Breast Cancer during Opening Press Conference here today, Wednesday December 11, 2019. during the San Antonio Breast Cancer Symposium being held at the Henry B. Gonzalez Convention Center in San Antonio, TX. This year is the 42nd Anniversary of the meeting where over 7,500 physicians, researchers, patient advocates and healthcare professionals from over 90 countries attended the meeting which features the latest research on breast cancer treatment and prevention. Photo by © MedMeetingImages/Todd Buchanan 2019 Technical Questions: todd@medmeetingimages.com